Publications by authors named "Francesca Nacci"

Claim this Profile
B
Balneotherapy in Fibromyalgia Syndrome: protocol of "FIBROTHERM", a prospective multi-center, two-cohort observational study.
Alarico Ariani, Giorgio Bedogni, Giovanni Biasi, Franco Cozzi, Sabrina Formisano, Francesca Nacci

Int J Biometeorol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for Leishmania spp. infection in patients treated with biologic agents for immune-mediated inflammatory diseases: results of an Italian multicentric prospective study.
Emma Balducelli, Ana Torres, Sara Morselli, Andrea Angheben, Chiara Piubelli, Francesca Nacci

Trop Med Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosomatic profile in patients with systemic sclerosis: results from an observational study.
Sara Romanazzo, Francesco Sera, Margherita Cappelli, Francesca Nacci, Serena Guiducci

Front Med (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Adipokines between Genders in the Pathogenesis of Osteoarthritis.
Alessio Economou, Ilenia Mallia, Antonella Fioravanti, Stefano Gentileschi, Francesca Nacci

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Babesiosis in the immunocompromised population: Results from a multicentric cohort study conducted in Italy.
Anna Barbiero, Simona Gabrielli, Lapo Dani, Michele Spinicci, Filippo Lagi, Francesca Nacci

Parasite Epidemiol Control· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of physiotherapy treatment in medium and long term in adults with fibromyalgia: an umbrella of systematic reviews.
Elio Carrasco-Vega, Serena Guiducci, Francesca Nacci, Silvia Bellando Randone, Chiara Bevilacqua

Clin Exp Rheumatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study.
Salvatore D'Angelo, Enrico Tirri, Angela Maria Giardino, Tiziana De Rosa, Marco Matucci-Cerinic, Francesca Nacci

Int J Rheum Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study.
Caterina Baldi, Simone Parisi, Paolo Falsetti, Jurgen Sota, Maria Chiara Ditto, Francesca Nacci

J Clin Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Questionnaires for the subjective evaluation of patients with fibromyalgia: a systematic review.
Elio Carrasco-Vega, Marta Martínez-Moya, Luca Barni, Serena Guiducci, Francesca Nacci

Eur J Phys Rehabil Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentric Reticulohistiocytosis Associated with an Early Form of Systemic Lupus Erythematosus: A Case Report of a Rare Disease, with Mini Review of the Literature.
Elena Biancamaria Mariotti, Alberto Corrà, Elisa Lemmi, Lucrezia Laschi, Cristina Aimo, Francesca Nacci

J Clin Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.
Salvatore D'Angelo, Enrico Tirri, Angela Maria Giardino, Marco Mattucci-Cerinic, Lorenzo Dagna, Francesca Nacci

J Clin Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database.
Marco Di Carlo, Sonia Farah, Laura Bazzichi, Fabiola Atzeni, Marcello Govoni, Francesca Nacci

Clin Exp Rheumatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry.
Fabiola Atzeni, Alessandra Alciati, Laura Bazzichi, Marcello Govoni, Giovanni Biasi, Francesca Nacci

Clin Exp Rheumatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life.
Khadija El Aoufy, Maria Ramona Melis, Silvia Bellando Randone, Jelena Blagojevic, Francesca Bartoli, Francesca Nacci

Clin Rheumatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases.
Cosimo Bruni, Cosimo Cigolini, Giulia Tesei, Laura Cometi, Francesca Bartoli, Francesca Nacci

Eur J Rheumatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis.
Cosimo Bruni, Stefano Gentileschi, Giovanni Pacini, Marco Bardelli, Lorenzo Tofani, Francesca Nacci

Ther Adv Musculoskelet Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib in the treatment of rheumatoid arthritis: clinical and ultrasound evaluation of a real-life single-centre experience.
Giulia Tesei, Laura Cometi, Francesca Nacci, Riccardo Terenzi, Lorenzo Tofani

Ther Adv Musculoskelet Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients.
Fabiola Atzeni, Alessandra Alciati, Fausto Salaffi, Marco Di Carlo, Laura Bazzichi, Francesca Nacci

Rheumatol Adv Pract· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients.
Fausto Salaffi, Marco Di Carlo, Laura Bazzichi, Fabiola Atzeni, Marcello Govoni, Francesca Nacci

Rheumatology (Oxford)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases.
Cosimo Bruni, Roberta Bitti, Francesca Nacci, Laura Cometi, Lorenzo Tofani

Clin Rheumatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Malignancy and Biologic Therapy in Rheumatic Inflammatory Diseases: A Single-center Experience.
Laura Cometi, Cosimo Bruni, Saverio Passavanti, Lorenzo Tofani, Francesca Bartoli, Francesca Nacci

Rheumatol Immunol Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases.
Cosimo Bruni, Stefano Gentileschi, Giovanni Pacini, Caterina Baldi, Marco Capassoni, Francesca Nacci

Ther Adv Musculoskelet Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases.
Laura Cometi, Cosimo Bruni, Nicolò Chiti, Lorenzo Tofani, Francesca Nacci

J Clin Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial.
Laura Bazzichi, Francesca Nacci, Luigi Sinigaglia, Laura Bianchino, Roberto Caporali

Clin Rheumatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability.
Francesca Bandinelli, Francesco Scazzariello, Emanuela Pimenta da Fonseca, Mittermayer Barreto Santiago, Claudio Marcassa, Francesca Nacci

Drug Des Devel Ther· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis